Cooley advised the underwriters on Audentes Therapeutics’ $86.3 million shelf-takedown offering of 5,955,151 shares of common stock, which includes 755,151 shares purchased pursuant to the underwriters’…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now